MDGeneticPro BRCA1 & BRCA2
Discover the Hereditary Risk for Breast Cancer.

Combating Breast Cancer. Together.
According to the National Breast Cancer Foundation, 1 in 8 women will develop breast cancer in her lifetime. On average, every 2 minutes a women is diagnosed with breast cancer in the US. These statistics continue to be alarming, but hereditary breast cancer screening can help detect the risk for both women and men.
With a simple blood draw, our advanced BRCA gene mutation testing identifies harmful variants in the BRCA1 or BRCA2 genes. We offer quick turnaround times with results in just 15 days.
Discover the risk. Live with confidence.
estimated 287,500 new cases of invasive breast cancer will be diagnosed in women in the U.S according to the National Breast Cancer Foundation.

Let’s Talk
We want to hear from you! Tell us more about your interest in MDChemistryPro today.

Read Our Blog
Next Generation Sequencing Solutions: COVID-19 (SARS-CoV-2) whole-genome sequencing, non-invasive prenatal diagnosis, and cancer screening.
Here at Premier Medical Laboratory Services (PMLS), our mission is to help physicians provide the best care to their patients while remaining an industry leader through cutting-edge technology and scientific innovation. Our Next...
Former Congressman Joe Cunningham and Senator Tim Scott’s Office Visit South Carolina’s Largest Laboratory, PMLS
In the past few months at Premier Medical Laboratory Services, we have had the pleasure of welcoming a few South Carolina politicians and their staff to our headquarters in Greenville, SC. Alongside Lindsey Graham's visit, two of the visits were from former...
U.S. Senator Lindsey Graham Speaks on The Importance of Variant Tracking During Tour of PMLS
~ Premier Medical Laboratory Services is conducting one of the largest-scale Next Generation Sequencing initiatives in the nation for variant tracking ~ Greenville, SC June, 17 2021 – US Senator Lindsey Graham recently viewed one of the largest variant surveillance...
Rutgers University and Premier Medical Laboratory Services Conduct Studies Showing TAG-NGPM+™ Inactivates SARS CoV-2 Virus, Increases Stability
~ Together, Rutgers and Premier are publishing a scientific article demonstrating their findings ~ Public Health Research Institute at Rutgers New Jersey Medical School and Premier Medical Laboratory Services (PMLS) have conducted studies on the stability and viral...
Nation-Leading COVID-19 Variant Surveillance Initiative Now Underway: Premier Medical Laboratory Services
The Biden Administration recently announced a $1.7 billion investment to monitor new and emerging COVID-19 variants which could induce another pandemic wave. Concurrently, to combat these mutated strains, advanced molecular diagnostics laboratory, Premier Medical...
PMLS Awarded: Healthcare Tech Outlook Top Genetic Diagnostic Solution Providers of 2021
Premier Medical Laboratory Services is designated as a top Genetic Diagnostic Solution Provider of 2021. This award comes as recognition for our laboratory's contributions to improving overall patient care with the most advanced diabetes and cardiovascular testing and...